by admin_63069 | Jul 29, 2024 | Related Topics
Study shows that PET/CT imaging using a new tracing agent is more accurate at determining the extent of prostate cancer than the current standard MRI for intermediate and high-risk cases.
by admin_63069 | Jul 24, 2024 | News You Can Use
Treatment of intermediate risk prostate cancer remains controversial.
by admin_63069 | Jul 22, 2024 | Related Topics
Key takeaways on the evolving landscape for imaging and biopsy in prostate cancer, highlighting the role for fusion-guided biopsy in the diagnosis and management of prostate cancer
by admin_63069 | Jul 17, 2024 | News You Can Use
Findings support PSMA PET in the preoperative workflow of intermediate- and high-risk tumors
by admin_63069 | Jul 15, 2024 | Related Topics
Key findings from the recent American Society of Clinical Oncology annual meeting
